Scalable wastewater surveillance for routine and emerging infectious disease pathogens EO 14398

Active Indefinite Delivery Contract Awarded

Contract number
75D30126D21689
Awardee
Awarding agency
Task orders
1 $5,580,766 obligated

Award facts

Opportunity
Combined order value
$5,580,766 Current and potential, with all options
Last date to order 2% complete
IDV ceiling 4% used
$145,000,000.00
Maximum order
$10,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The CDC Pittsburgh (National Center for Emerging and Zoonotic Infectious Diseases / Division of Integrated Disease Surveillance and Response) awarded a single-award Indefinite Delivery Contract to Verily Life Sciences LLC on September 29, 2026, with a ceiling of $145 million and ultimate completion date of September 27, 2031.

The contract procures scalable wastewater surveillance capabilities to detect routine and emerging infectious disease pathogens across multiple jurisdictions. The CDC intends to develop and implement wastewater surveillance systems that adapt to newly identified pathogens, with technical scope encompassing scalability of surveillance systems, detection methodologies, data integration capabilities, and implementation across diverse wastewater treatment facilities.

The contract emerged from pre-solicitation RFQ 75D301-26-R-73475, posted July 1, 2026, with a capability statement deadline of July 22, 2026. No set-aside applies. Place of performance is not specified in the source. Work is intended to support the CDC's public health infrastructure modernization effort under Executive Order 14398, leveraging contractor expertise in collecting and activating health data for federal disease surveillance programs.

Task orders

Task order Ordering agency Obligated Awarded
Scalable wastewater surveillance for routine and emerging infectious disease pathogens EO 14398 75D30126F00001 CDC Pittsburgh $5,580,766

Quick answers

Who was awarded contract 75D30126D21689?

75D30126D21689 was awarded to Verily Life Sciences LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 29, 2026.

How much is contract 75D30126D21689 worth?

Orders under 75D30126D21689 have obligated $5,580,766. 75D30126D21689's own ceiling is $145,000,000. A single order can be worth up to $10,000.

How many orders have been placed under contract 75D30126D21689?

1 order has been placed under 75D30126D21689, the latest on September 29, 2026.

Who can order from contract 75D30126D21689?

75D30126D21689 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75D30126D21689 competed?

The extent of competition for 75D30126D21689 was full and open competition. The government received 7 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV